Atherosclerosis
Volume 192, Issue 2 , Pages 283-290 , June 2007

Macrophage-specific inhibition of NF-κB activation reduces foam-cell formation

  • Valérie Ferreira

      Affiliations

    • Department of Medical Biochemistry, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    • Corresponding Author InformationCorresponding author. Tel.: +31 20 5665153; fax: +31 20 6915519.
    • ,
  • Ko Willems van Dijk

      Affiliations

    • Department of Human Genetics, Leiden University Medical Center, The Netherlands
    • Department of General Internal Medicine, Leiden University Medical Center, The Netherlands
    • ,
  • Albert K. Groen

      Affiliations

    • Department of Medical Biochemistry, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    • ,
  • Rogier M. Vos

      Affiliations

    • Department of Medical Biochemistry, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    • ,
  • Jos van der Kaa

      Affiliations

    • Department of Transgenic Facility, Leiden University Medical Center, The Netherlands
    • ,
  • Marion J.J. Gijbels

      Affiliations

    • Department of Molecular Genetics, University of Maastricht, Maastricht, The Netherlands
    • ,
  • Louis M. Havekes

      Affiliations

    • Department of Cardiology, Leiden University Medical Center, The Netherlands
    • Organization for Applied Scientific Research (TNO)-Prevention and Health, Gaubius Laboratory, Leiden, The Netherlands
    • ,
  • Hans Pannekoek

      Affiliations

    • Department of Medical Biochemistry, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

Received 10 March 2006 ,Revised 19 July 2006 ,Accepted 19 July 2006.

References 

  1. Ross R. Atherosclerosis—an inflammatory disease. N Engl J Med. 1999;340:115–126
  2. Davies PF. Flow-mediated endothelial mechanotransduction. Physiol Rev. 1995;75:519–560
  3. Karin M. The beginning of the end: IkappaB kinase (IKK) and NF-kappaB activation. J Biol Chem. 1999;274:27339–27342
  4. Baldwin AS. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol. 1996;14:649–683
  5. Baeuerle PA, Baltimore D. NF-kappa B: ten years after. Cell. 1996;87:13–20
  6. Palombella VJ, Rando OJ, Goldberg AL, Maniatis T. The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B. Cell. 1994;78:773–785
  7. Scherer DC, Brockman JA, Chen Z, Maniatis T, Ballard DW. Signal-induced degradation of I kappa B alpha requires site-specific ubiquitination. Proc Natl Acad Sci USA. 1995;92:11259–11263
  8. Finco TS, Baldwin AS. Mechanistic aspects of NF-kappa B regulation: the emerging role of phosphorylation and proteolysis. Immunity. 1995;3:263–272
  9. Traenckner E, Pahl H, Henkel T, et al. Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli. EMBO J. 1995;14:2876–2883
  10. Ferreira V, Tarantino N, Korner M. Discrimination between RelA and RelB transcriptional regulation by a dominant negative mutant of IkappaBalpha. J Biol Chem. 1998;273:592–599
  11. Ferreira V, Sidenius N, Tarantino N, et al. In vivo inhibition of NF-kappa B in T-lineage cells leads to a dramatic decrease in cell proliferation and cytokine production and to increased cell apoptosis in response to mitogenic stimuli, but not to abnormal thymopoiesis. J Immunol. 1999;162:6442–6450
  12. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801–809
  13. Baeuerle PA, Henkel T. Function and activation of NF-kappa B in the immune system. Annu Rev Immunol. 1994;12:141–179
  14. Brand K, Page S, Rogler G, et al. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J Clin Invest. 1996;97:1715–1722
  15. Kanters E, Gijbels MJ, van der Made I, et al. Hematopoietic NF-kappaB1 deficiency results in small atherosclerotic lesions with an inflammatory phenotype. Blood. 2004;103:934–940
  16. Kanters E, Pasparakis M, Gijbels MJ, et al. Inhibition of NF-kappaB activation in macrophages increases atherosclerosis in LDL receptor-deficient mice. J Clin Invest. 2003;112:1176–1185
  17. Bouwmeester T, Bauch A, Ruffner H, et al. A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway. Nat Cell Biol. 2004;6:97–105
  18. Auwerx J. The human leukemia cell line, THP-1: a multifacetted model for the study of monocyte-macrophage differentiation. Experientia. 1991;47:22–31
  19. Mikita T, Porter G, Lawn RM, Shiffman D. Oxidized low density lipoprotein exposure alters the transcriptional response of macrophages to inflammatory stimulus. J Biol Chem. 2001;276:45729–45739
  20. Febbraio M, Hajjar DP, Silverstein RL. CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J Clin Invest. 2001;108:785–791
  21. Joseph SB, Castrillo A, Laffitte BA, Mangelsdorf DJ, Tontonoz P. Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat Med. 2003;9:213–219
  22. Horvai A, Palinski W, Wu H, et al. Scavenger receptor A gene regulatory elements target gene expression to macrophages and to foam cells of atherosclerotic lesions. Proc Natl Acad Sci USA. 1995;92:5391–5395
  23. Moore KJ, Rosen ED, Fitzgerald ML, et al. The role of PPAR-gamma in macrophage differentiation and cholesterol uptake. Nat Med. 2001;7:41–47
  24. Chawla A, Barak Y, Nagy L, et al. PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nat Med. 2001;7:48–52
  25. Chinetti G, Lestavel S, Bocher V, et al. PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway. Nat Med. 2001;7:53–58
  26. Repa JJ, Turley SD, Lobaccaro JA, et al. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science. 2000;289:1524–1529
  27. Lee CH, Evans RM. Peroxisome proliferator-activated receptor-gamma in macrophage lipid homeostasis. Trends Endocrinol Metab. 2002;13:331–335
  28. Llodra J, Angeli V, Liu J, et al. Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques. Proc Natl Acad Sci USA. 2004;101:11779–11784
  29. Gerbod-Giannone MC, Li Y, Holleboom A, et al. TNFα induces ABCA1 through NF-kB in macrophages and in phagocytes ingesting apoptotic cells. Proc Natl Acad Sci USA. 2006;103:3112–3117

PII: S0021-9150(06)00440-0

doi: 10.1016/j.atherosclerosis.2006.07.018

Atherosclerosis
Volume 192, Issue 2 , Pages 283-290 , June 2007

Article Tools

* Image Usage & Resolution